07-Mar-2008 - A US Food and Drug Administration (FDA) investigation into the recent Baxter heparin scare has uncovered a contaminant in the product that was sourcing the active pharmaceutical ingredient (API) from a Chinese manufacturer.
Link to Article
In-Pharmatechnologist.com
|
|
||||||||
|
This Month
Month Archive
RSS Newsfeeds
Main Page RSS
|
Heparin contamination emerges after FDA China investigation
No comments found.
|
Search
Links
|
||||||